167.78
price up icon3.82%   6.2831
 
loading

Icon Plc Aktie (ICLR) Neueste Nachrichten

pulisher
Jul 22, 2025

ICON plc Stock Takes Center Stage. What’s Next? - StocksToTrade

Jul 22, 2025
pulisher
Jul 22, 2025

ICON plc’s Market Surge: Examining Strong Moves - timothysykes.com

Jul 22, 2025
pulisher
Jul 22, 2025

ICON plc Emerges as Phase 1 Clinical Trials Leader in New Benchmark Report - StocksToTrade

Jul 22, 2025
pulisher
Jul 22, 2025

ICON plc Emerges as Top Contender in Clinical Research Arena - timothysykes.com

Jul 22, 2025
pulisher
Jul 22, 2025

Icon (ICLR) Shares Surge Over 14% to Reach $160 | ICLR Stock New - GuruFocus

Jul 22, 2025
pulisher
Jul 21, 2025

ICON PLC expected to post earnings of $3.21 a shareEarnings Preview - TradingView

Jul 21, 2025
pulisher
Jul 20, 2025

Icon ICLR 2025Q2 Earnings Preview Downside Risk Amid Macroeconomic Issues and Trial Delays - AInvest

Jul 20, 2025
pulisher
Jul 19, 2025

Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

ICON (NASDAQ:ICLR) Seems To Use Debt Quite Sensibly - 富途牛牛

Jul 18, 2025
pulisher
Jul 18, 2025

Medical Device Regulatory Affairs Market Key Players Analysis - openPR.com

Jul 18, 2025
pulisher
Jul 16, 2025

Launch Your Career as a Life Science Intern at ICON, Apply Now! - BioTecNika

Jul 16, 2025
pulisher
Jul 16, 2025

ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report - Lelezard

Jul 16, 2025
pulisher
Jul 16, 2025

ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report - Business Wire

Jul 16, 2025
pulisher
Jul 15, 2025

Do You Believe in the Upside Potential of ICON PLC (ICLR)? - Insider Monkey

Jul 15, 2025
pulisher
Jul 14, 2025

Clinical Trial Investigative Site Network Market Top Players - openPR.com

Jul 14, 2025
pulisher
Jul 13, 2025

Icon (ICLR) Gets a Buy from Leerink Partners - The Globe and Mail

Jul 13, 2025
pulisher
Jul 10, 2025

Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating, Announces Target Price $187 - 富途牛牛

Jul 10, 2025
pulisher
Jul 09, 2025

ICON plc stock price target lowered to $187 at Truist Securities - Investing.com Nigeria

Jul 09, 2025
pulisher
Jul 09, 2025

ICON plc stock price target lowered to $187 at Truist Securities By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 09, 2025

WCM Investment Management Reduces Stake in Icon PLC, Focuses on Tech and Financial Sectors - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

WCM Investment Management, LLC Significantly Reduces Stake in Ic - GuruFocus

Jul 08, 2025
pulisher
Jul 08, 2025

WCM Investment Management, LLC Significantly Reduces Stake in Icon PLC - GuruFocus

Jul 08, 2025
pulisher
Jul 07, 2025

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability - 01net

Jul 07, 2025
pulisher
Jul 07, 2025

ICON and Its Employees Recognised as Clinical Research Industry - GuruFocus

Jul 07, 2025
pulisher
Jul 05, 2025

Should You Hold ICON PLC (ICLR)? - MSN

Jul 05, 2025
pulisher
Jul 03, 2025

Will ICON PLC (ICLR) Benefit from R&D Spending? - Insider Monkey

Jul 03, 2025
pulisher
Jun 25, 2025

ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued? - Seeking Alpha

Jun 25, 2025
pulisher
Jun 23, 2025

ICON plc Schedules Q2 2025 Earnings Call - TipRanks

Jun 23, 2025
pulisher
Jun 23, 2025

ICON Announces Q2 2025 Earnings Call - AInvest

Jun 23, 2025
pulisher
Jun 18, 2025

ICON plc Reports Strong Interim Financial Results for Early 2025 - TipRanks

Jun 18, 2025
pulisher
Jun 17, 2025

Icon (ICLR) Receives Positive Rating from Truist Financial Analyst - AInvest

Jun 17, 2025
pulisher
Jun 13, 2025

Medical Device Regulatory Affairs Market Top PlayersICON, - openPR.com

Jun 13, 2025
pulisher
Jun 11, 2025

ICON plc Announces 2025 AGM and Key Resolutions - TipRanks

Jun 11, 2025
pulisher
Jun 07, 2025

Icon PLC (ICLR) Shares Up 3.47% on Jun 6 - GuruFocus

Jun 07, 2025
pulisher
Jun 05, 2025

Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - GlobeNewswire Inc.

Jun 05, 2025
pulisher
Jun 05, 2025

ICON Public Limited (NASDAQ:ICLR) Short Interest Up 25.4% in May - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Icon PLC (ICLR) Stock Price Up 4.49% on Jun 4 - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

ICON at William Blair Conference: Strategic Focus Amid Challenges - Investing.com

Jun 04, 2025
pulisher
Jun 03, 2025

ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review - mx.advfn.com

Jun 03, 2025
pulisher
Jun 02, 2025

Here's Why You Should Retain ICLR Stock in Your Portfolio Now - TradingView

Jun 02, 2025
pulisher
May 30, 2025

Icon PLC (ICLR) Down 9.7% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

May 30, 2025
pulisher
May 27, 2025

ICON plc to Present at the William Blair 45th Annual Growth Stoc - GuruFocus

May 27, 2025
pulisher
May 27, 2025

ICON plc to Present at Annual Growth Stock Conference By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

ICLR December 2026 Options Begin Trading - Nasdaq

May 27, 2025
pulisher
May 27, 2025

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference - BioSpace

May 27, 2025
pulisher
May 27, 2025

ICON plc to Present at Annual Growth Stock Conference - Investing.com

May 27, 2025
pulisher
May 27, 2025

ICON plc to Present at William Blair Growth Stock Conference - TipRanks

May 27, 2025
pulisher
May 25, 2025

ICON’s SWOT analysis: cro stock faces headwinds amid potential rebound - Investing.com

May 25, 2025
pulisher
May 23, 2025

ICON Life Science Internship For BSc & MSc – Applications Closing Soon! Hurry! - BioTecNika

May 23, 2025
pulisher
May 23, 2025

Redburn Atlantic Adjusts Icon (ICLR) Price Target Amid Market Uncertainty | ICLR Stock News - GuruFocus

May 23, 2025
diagnostics_research WAT
$295.72
price up icon 2.88%
$137.87
price down icon 1.68%
diagnostics_research DGX
$170.01
price down icon 4.60%
diagnostics_research LH
$249.01
price down icon 1.18%
diagnostics_research MTD
$1,257.05
price up icon 3.10%
diagnostics_research IQV
$193.55
price up icon 3.25%
Kapitalisierung:     |  Volumen (24h):